CA Stock MarketDetailed Quotes

QNTM Quantum BioPharma Ltd

Watchlist
  • 7.000
  • +0.200+2.94%
15min DelayTrading Nov 7 10:37 ET
13.00MMarket Cap-393P/E (TTM)

Quantum BioPharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-36.45%3.47M
-75.77%2.25M
-28.65%19.57M
-71.45%1.9M
-54.35%3.31M
-25.89%5.46M
57.63%9.3M
-18.71%27.43M
8.84%6.66M
41.33%7.25M
Selling and administrative expenses
-11.22%2.44M
-66.32%1.97M
-17.37%13.2M
-35.55%1.81M
-24.60%3.2M
-43.13%2.74M
51.71%5.86M
-31.62%15.98M
-32.51%2.81M
0.14%4.24M
-General and administrative expense
-11.22%2.44M
-66.32%1.97M
-17.37%13.2M
-35.55%1.81M
-24.60%3.2M
-43.13%2.74M
51.71%5.86M
-31.62%15.98M
-32.51%2.81M
0.14%4.24M
Research and development costs
-44.24%897.99K
-93.07%160.26K
-44.16%3.86M
-101.11%-29.96K
-101.77%-32.99K
14.05%1.61M
146.69%2.31M
9.21%6.91M
216.16%2.69M
1,840.41%1.87M
Depreciation amortization depletion
-87.64%136.81K
-89.37%120.14K
-44.76%2.51M
-89.44%122.22K
-87.19%146.81K
-2.21%1.11M
2.62%1.13M
12.16%4.54M
4.54%1.16M
14.08%1.15M
-Depreciation and amortization
-87.64%136.81K
-89.37%120.14K
-44.76%2.51M
-89.44%122.22K
-87.19%146.81K
-2.21%1.11M
2.62%1.13M
12.16%4.54M
4.54%1.16M
14.08%1.15M
Operating profit
36.45%-3.47M
75.77%-2.25M
28.65%-19.57M
71.45%-1.9M
54.35%-3.31M
25.89%-5.46M
-57.63%-9.3M
18.71%-27.43M
-8.84%-6.66M
-41.33%-7.25M
Net non-operating interest income (expenses)
-48.40%96.07K
-41.07%160.11K
146.48%786.06K
-48.72%153.78K
252.80%174.45K
1,426.42%186.16K
1,758.37%271.67K
568.22%318.91K
1,126.82%299.88K
2,626.67%49.45K
Non-operating interest income
-43.91%104.42K
-36.65%172.52K
113.84%786.36K
-48.74%153.79K
165.76%174.07K
8,293.28%186.16K
--272.34K
28,362.46%367.74K
--300.02K
--65.5K
Non-operating interest expense
--8.36K
1,761.17%12.41K
-99.39%299
-91.11%12
----
--0
-95.93%667
-29.66%48.82K
-99.54%135
720.24%16.05K
Total other finance cost
----
----
----
----
---380
----
----
----
----
----
Other net income (expenses)
110.41%22.33K
100.18%1.68K
35.97%553.46K
-54.59%96.02K
2,545.66%2.01M
63.12%-214.5K
-304.58%-930.28K
422.57%407.04K
1,514.39%211.45K
115.79%75.83K
Gain on sale of security
-96.80%22.33K
104.25%19.15K
-40.80%170.25K
56.73%332.2K
-115.19%-5.86K
220.04%698.1K
-221.02%-450.18K
263.42%287.58K
1,517.77%211.96K
108.04%38.6K
Special income (charges)
--0
96.36%-17.48K
---4.56M
---236.19K
--0
---3.84M
---480.1K
--0
--0
--0
-Less:Impairment of capital assets
----
----
--4.56M
--236.19K
--0
----
----
--0
--0
--0
-Less:Other special charges
----
--17.48K
----
----
----
----
----
----
----
----
-Less:Write off
--0
--0
----
----
----
--3.84M
--480.1K
----
----
----
Other non-operating income (expenses)
----
----
4,034.69%4.94M
--0
5,303.91%2.01M
--2.93M
----
139.90%119.45K
---506
--37.23K
Income before tax
38.94%-3.35M
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
84.13%-1.13M
31.07%-5.49M
-82.34%-9.96M
21.32%-26.7M
0.24%-6.15M
-26.97%-7.13M
Income tax
Earnings from equity interest net of tax
Net income
38.94%-3.35M
79.00%-2.09M
22.77%-18.23M
73.14%-1.65M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
-23.10%-7.13M
Net income continuous operations
38.94%-3.35M
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
84.13%-1.13M
31.07%-5.49M
-82.34%-9.96M
21.32%-26.7M
0.24%-6.15M
-26.97%-7.13M
Net income discontinuous operations
----
----
--0
--0
--0
----
----
329.83%3.1M
--0
--0
Noncontrolling interests
-240.58K
-188.05K
-328.41K
0
0
0
Net income attributable to the company
43.32%-3.11M
80.89%-1.9M
24.17%-17.9M
78.48%-1.32M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
-23.10%-7.13M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
43.32%-3.11M
80.89%-1.9M
24.17%-17.9M
78.48%-1.32M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
-23.10%-7.13M
Diluted earnings per share
42.86%-5.2
80.77%-3.25
24.59%-29.9
75.00%-2.6
84.21%-1.95
-16.67%-9.1
-73.33%-16.9
39.60%-39.65
-23.08%-10.4
-26.67%-12.35
Basic earnings per share
42.86%-5.2
80.77%-3.25
24.59%-29.9
75.00%-2.6
84.21%-1.95
-16.67%-9.1
-73.33%-16.9
39.60%-39.65
-23.08%-10.4
-26.67%-12.35
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -36.45%3.47M-75.77%2.25M-28.65%19.57M-71.45%1.9M-54.35%3.31M-25.89%5.46M57.63%9.3M-18.71%27.43M8.84%6.66M41.33%7.25M
Selling and administrative expenses -11.22%2.44M-66.32%1.97M-17.37%13.2M-35.55%1.81M-24.60%3.2M-43.13%2.74M51.71%5.86M-31.62%15.98M-32.51%2.81M0.14%4.24M
-General and administrative expense -11.22%2.44M-66.32%1.97M-17.37%13.2M-35.55%1.81M-24.60%3.2M-43.13%2.74M51.71%5.86M-31.62%15.98M-32.51%2.81M0.14%4.24M
Research and development costs -44.24%897.99K-93.07%160.26K-44.16%3.86M-101.11%-29.96K-101.77%-32.99K14.05%1.61M146.69%2.31M9.21%6.91M216.16%2.69M1,840.41%1.87M
Depreciation amortization depletion -87.64%136.81K-89.37%120.14K-44.76%2.51M-89.44%122.22K-87.19%146.81K-2.21%1.11M2.62%1.13M12.16%4.54M4.54%1.16M14.08%1.15M
-Depreciation and amortization -87.64%136.81K-89.37%120.14K-44.76%2.51M-89.44%122.22K-87.19%146.81K-2.21%1.11M2.62%1.13M12.16%4.54M4.54%1.16M14.08%1.15M
Operating profit 36.45%-3.47M75.77%-2.25M28.65%-19.57M71.45%-1.9M54.35%-3.31M25.89%-5.46M-57.63%-9.3M18.71%-27.43M-8.84%-6.66M-41.33%-7.25M
Net non-operating interest income (expenses) -48.40%96.07K-41.07%160.11K146.48%786.06K-48.72%153.78K252.80%174.45K1,426.42%186.16K1,758.37%271.67K568.22%318.91K1,126.82%299.88K2,626.67%49.45K
Non-operating interest income -43.91%104.42K-36.65%172.52K113.84%786.36K-48.74%153.79K165.76%174.07K8,293.28%186.16K--272.34K28,362.46%367.74K--300.02K--65.5K
Non-operating interest expense --8.36K1,761.17%12.41K-99.39%299-91.11%12------0-95.93%667-29.66%48.82K-99.54%135720.24%16.05K
Total other finance cost -------------------380--------------------
Other net income (expenses) 110.41%22.33K100.18%1.68K35.97%553.46K-54.59%96.02K2,545.66%2.01M63.12%-214.5K-304.58%-930.28K422.57%407.04K1,514.39%211.45K115.79%75.83K
Gain on sale of security -96.80%22.33K104.25%19.15K-40.80%170.25K56.73%332.2K-115.19%-5.86K220.04%698.1K-221.02%-450.18K263.42%287.58K1,517.77%211.96K108.04%38.6K
Special income (charges) --096.36%-17.48K---4.56M---236.19K--0---3.84M---480.1K--0--0--0
-Less:Impairment of capital assets ----------4.56M--236.19K--0----------0--0--0
-Less:Other special charges ------17.48K--------------------------------
-Less:Write off --0--0--------------3.84M--480.1K------------
Other non-operating income (expenses) --------4,034.69%4.94M--05,303.91%2.01M--2.93M----139.90%119.45K---506--37.23K
Income before tax 38.94%-3.35M79.00%-2.09M31.73%-18.23M73.14%-1.65M84.13%-1.13M31.07%-5.49M-82.34%-9.96M21.32%-26.7M0.24%-6.15M-26.97%-7.13M
Income tax
Earnings from equity interest net of tax
Net income 38.94%-3.35M79.00%-2.09M22.77%-18.23M73.14%-1.65M84.13%-1.13M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M-23.10%-7.13M
Net income continuous operations 38.94%-3.35M79.00%-2.09M31.73%-18.23M73.14%-1.65M84.13%-1.13M31.07%-5.49M-82.34%-9.96M21.32%-26.7M0.24%-6.15M-26.97%-7.13M
Net income discontinuous operations ----------0--0--0--------329.83%3.1M--0--0
Noncontrolling interests -240.58K-188.05K-328.41K000
Net income attributable to the company 43.32%-3.11M80.89%-1.9M24.17%-17.9M78.48%-1.32M84.13%-1.13M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M-23.10%-7.13M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 43.32%-3.11M80.89%-1.9M24.17%-17.9M78.48%-1.32M84.13%-1.13M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M-23.10%-7.13M
Diluted earnings per share 42.86%-5.280.77%-3.2524.59%-29.975.00%-2.684.21%-1.95-16.67%-9.1-73.33%-16.939.60%-39.65-23.08%-10.4-26.67%-12.35
Basic earnings per share 42.86%-5.280.77%-3.2524.59%-29.975.00%-2.684.21%-1.95-16.67%-9.1-73.33%-16.939.60%-39.65-23.08%-10.4-26.67%-12.35
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data